Urologic Health Secures $11M Seed Funding Round

Deal Summary

Urologic Health, a medical device company developing non‑invasive urodynamic diagnostics, announced the closing of an $11 million seed financing round. The round was led by an undisclosed strategic investor and included Edge Medical Ventures, SHD Partners and Longevity Venture Partners, with the capital earmarked for clinical validation, FDA 510(k) clearance and U.S. commercialization.